Lund, Sweden

Mattias Collin

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mattias Collin

Introduction

Mattias Collin is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of medical science, particularly in the treatment of diseases mediated by IgE antibodies. With a total of 4 patents to his name, Collin's work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on a treatment for IgE-mediated diseases. This invention provides an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, for use in a method for treating or preventing a disease or condition mediated by IgE antibodies. Another significant patent involves an endoglycosidase known as EndoS49, which has specific endoglycosidase activity on native IgG and cleaves a larger variety of Fc glycans than EndoS. A mutant of EndoS49 was also produced, which lacks endoglycosidase activity but is capable of binding to IgG. Methods using EndoS49, deletions thereof, and the mutant are disclosed, especially for assessing glycosylation of IgG or for isolating IgG.

Career Highlights

Throughout his career, Mattias Collin has worked with prominent companies such as Hansa Medical AB and Genovis AB. His innovative work in these organizations has contributed to advancements in medical treatments and research.

Collaborations

Some of his notable coworkers include Maria Allhorn and Falk Nimmerjahn. Their collaborative efforts have further enhanced the research and development of new medical technologies.

Conclusion

Mattias Collin's contributions to the field of medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…